<SEC-DOCUMENT>0001520138-18-000136.txt : 20180703
<SEC-HEADER>0001520138-18-000136.hdr.sgml : 20180703
<ACCEPTANCE-DATETIME>20180703160114
ACCESSION NUMBER:		0001520138-18-000136
CONFORMED SUBMISSION TYPE:	PRE 14C
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20180703
FILED AS OF DATE:		20180703
DATE AS OF CHANGE:		20180703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOVIE INC.
		CENTRAL INDEX KEY:			0001580149
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				462510769
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		PRE 14C
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-55292
		FILM NUMBER:		18937033

	BUSINESS ADDRESS:	
		STREET 1:		100 CUMMINGS CENTER,
		STREET 2:		SUITE 247-C
		CITY:			BEVERLY
		STATE:			MA
		ZIP:			01915
		BUSINESS PHONE:		312-283-5793

	MAIL ADDRESS:	
		STREET 1:		100 CUMMINGS CENTER,
		STREET 2:		SUITE 247-C
		CITY:			BEVERLY
		STATE:			MA
		ZIP:			01915

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NANOANTIBIOTICS, INC.
		DATE OF NAME CHANGE:	20130625
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14C
<SEQUENCE>1
<FILENAME>bivi-20180703_pre14c.htm
<DESCRIPTION>PRE 14C
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 9pt 0 0; text-align: center"><B>SCHEDULE 14C INFORMATION</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 9pt 0 0; text-align: center">Information Statement Pursuant to Section
14(c) of the Securities</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Check the appropriate box:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 23.75pt"><FONT STYLE="font-family: MS Gothic, Helvetica, Sans-Serif">&#9746;</FONT></TD><TD>Preliminary Information Statement</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 23.75pt"><FONT STYLE="font-family: MS Gothic, Helvetica, Sans-Serif">&#9744;</FONT></TD><TD>Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2))</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 23.75pt"><FONT STYLE="font-family: MS Gothic, Helvetica, Sans-Serif">&#9744;</FONT></TD><TD>Definitive Information Statement</TD></TR></TABLE>

<P STYLE="font: 20pt Times New Roman, Times, Serif; margin: 9pt 0 0; text-align: center; border-bottom: Black 0.5pt solid"><B>BIOVIE
INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Name of Registrant as Specified In Its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Payment of Filing Fee (Check the appropriate box):</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 23.75pt"><FONT STYLE="font-family: MS Gothic, Helvetica, Sans-Serif">&#9746;</FONT></TD><TD>No fee required.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 23.75pt"><FONT STYLE="font-family: MS Gothic, Helvetica, Sans-Serif">&#9744;</FONT></TD><TD>Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24pt"></TD><TD STYLE="width: 24pt">1)</TD><TD>Title of each class of securities to which transaction applies:</TD></TR></TABLE>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 0in 1pt 23.75pt"><DIV STYLE="font-size: 1pt; border-top: Black 0.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24pt"></TD><TD STYLE="width: 24pt">2)</TD><TD>Aggregate number of securities to which transaction applies:</TD></TR></TABLE>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 0in 1pt 23.75pt"><DIV STYLE="font-size: 1pt; border-top: Black 0.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24pt"></TD><TD STYLE="width: 24pt">3)</TD><TD>Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on
which the filing fee is calculated and state how it was determined):</TD></TR></TABLE>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 0in 1pt 23.75pt"><DIV STYLE="font-size: 1pt; border-top: Black 0.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24pt"></TD><TD STYLE="width: 24pt">4)</TD><TD>Proposed maximum aggregate value of transaction:</TD></TR></TABLE>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 0in 1pt 23.75pt"><DIV STYLE="font-size: 1pt; border-top: Black 0.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24pt"></TD><TD STYLE="width: 24pt">5)</TD><TD>Total fee paid:</TD></TR></TABLE>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 0in 1pt 23.75pt"><DIV STYLE="font-size: 1pt; border-top: Black 0.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24pt"><FONT STYLE="font-family: MS Gothic, Helvetica, Sans-Serif">&#9744;</FONT></TD><TD>Fee paid previously with preliminary materials.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 23.75pt"><FONT STYLE="font-family: MS Gothic, Helvetica, Sans-Serif">&#9744;</FONT></TD><TD>Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and
the date of its filing.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24pt"></TD><TD STYLE="width: 24pt">1)</TD><TD>Amount Previously Paid:</TD></TR></TABLE>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 0in 1pt 23.75pt"><DIV STYLE="font-size: 1pt; border-top: Black 0.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24pt"></TD><TD STYLE="width: 24pt">2)</TD><TD>Form, Schedule or Registration Statement No.:</TD></TR></TABLE>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 0in 1pt 23.75pt"><DIV STYLE="font-size: 1pt; border-top: Black 0.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24pt"></TD><TD STYLE="width: 24pt">3)</TD><TD>Filing Party:</TD></TR></TABLE>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 0in 1pt 23.75pt"><DIV STYLE="font-size: 1pt; border-top: Black 0.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24pt"></TD><TD STYLE="width: 24pt">4)</TD><TD>Date Filed:</TD></TR></TABLE>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 23.75pt; text-indent: -23.75pt; border-bottom: Black 0.5pt solid">&nbsp;</P>

<P STYLE="font: 2pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 2pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">INFORMATION STATEMENT OF BIOVIE INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">100 Cummings Center, Suite 247-C&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Beverly, MA 01915</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Telephone (312) 283-5793</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTICE OF ACTION TAKEN WITHOUT A STOCKHOLDERS
MEETING</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Mailing: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2018</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">To the Stockholders of BioVie Inc.:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The accompanying Information Statement is furnished
to holders of shares of common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;), of BioVie Inc. (the &#8220;Company&#8221;).
Our Board of Directors approved on July 2, 2018, and recommended the approval by our stockholders of, an amendment to our Articles
of Incorporation to increase the total number of authorized shares of common stock from 300,000,000 to 800,000,000.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Certain of our stockholders, holding a majority
of our voting power on July 3, 2018, approved the amendment of our Articles of Incorporation by written consent in lieu of a special
meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The amendment of our Articles of Incorporation
will not be effective until a Certificate of Amendment is filed with the Secretary of State of the State of Nevada. We intend to
file the Certificate of Amendment as soon as practicable, but not less than twenty (20) calendar days after the accompanying Information
Statement is first mailed to our stockholders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>No action is required by you. </B>The accompanying
Information Statement is furnished only to inform our stockholders of the action described above before it takes effect in accordance
with Rule 14c-2 promulgated under the Securities Exchange Act of 1934, as amended. This Information Statement is being mailed or
otherwise provided to you on or about &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2018.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>WE ARE <U>NOT</U> ASKING YOU FOR A PROXY
AND YOU ARE REQUESTED <U>NOT</U> TO SEND US A PROXY.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">PLEASE NOTE THAT THE HOLDERS OF A MAJORITY OF
OUR OUTSTANDING SHARES OF COMMON STOCK HAVE ALREADY APPROVED THE AMENDMENT OF OUR ARTICLES OF INCORPORATION BY WRITTEN CONSENT
IN LIEU OF A MEETING. SUCH WRITTEN CONSENT IS SUFFICIENT TO SATISFY THE STOCKHOLDER VOTE REQUIREMENTS UNDER NEVADA LAW AND NO ADDITIONAL
VOTING WILL CONSEQUENTLY BE NEEDED TO APPROVE THESE MATTERS.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Please carefully read the enclosed document
in its entirety. You may also obtain other information about the Company from publicly available documents that have been filed
with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in">By Order of the Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in"><U>/s/ Jonathan Adams&#9;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in">Jonathan Adams</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in">Director and Chief Operating Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-bottom: Black 1pt solid"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">BIOVIE INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">100 Cummings Center, Suite 247-C&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Beverly, MA 01915</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">INFORMATION STATEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This Information Statement
is being furnished to stockholders of BioVie, Inc., a Nevada corporation (the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221;
or &#8220;our&#8221;), to advise you of corporate action approved without a meeting by written consent of our stockholders holding
a majority of our outstanding common stock. Such corporate action is the adoption of an amendment to our Articles of Incorporation
to increase our authorized capitalization from 300,000,000 shares of Class A common stock, par value $0.0001 per share (referred
to herein as the common stock), and 10,000,000 shares of preferred stock, par value $0.001 per share, to 800,000,000 shares of
common stock and 10,000,000 shares of preferred stock, by filing an amendment to our Articles of Incorporation (the &#8220;Charter
Amendment&#8221;). We are not increasing our authorized preferred stock which will remain unchanged. Approval of the Charter Amendment
requires the affirmative vote of a majority of the outstanding shares of common stock entitled to vote thereon. There are no dissenters&#8217;
rights applicable to the Charter Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A copy of the form of Certificate
of Amendment to our Articles of Incorporation to be filed in connection with the Charter Amendment is attached to this Information
Statement as <U>Appendix A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our Board of Directors,
by written consent on July 2, has approved, and stockholders holding 53,863,299 shares (approximately 54.7%) of our outstanding
common stock on July 3, 2018 (the &#8220;Majority Stockholders&#8221;), have consented in writing to the Charter Amendment. On
July 3, 2018 we had approximately 98,503,199 shares of common stock issued and outstanding. Accordingly, all corporate actions
necessary to authorize the Charter Amendment have been taken. Under Section 78.320 of the Nevada Revised Statutes (&#8220;NRS&#8221;),
any action required or permitted by the NRS to be taken at an annual or special meeting of stockholders of a Nevada corporation
may be taken without a meeting, without prior notice and without a vote, if a consent in writing, setting forth the action so taken,
is signed by the holders of outstanding stock having at least a majority of the voting power that would be necessary to authorize
or take such action at a meeting. In accordance with the regulations under the Securities Exchange Act of 1934, as amended (the
&#8220;Exchange Act&#8221;), the Charter Amendment will not become effective until at least 20 days after we have first mailed
this Information Statement to our stockholders. Promptly following the expiration of this 20-day period, we intend to file a Certificate
of Amendment to our Articles of Incorporation to effect the Charter Amendment. The proposed increase in the number of authorized
shares of our common stock will become effective at the time of the filing of the Charter Amendment or at such other time as provided
in the Charter Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>PLEASE BE ADVISED THAT
THIS IS ONLY AN INFORMATION STATEMENT. WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our executive offices are
located at 100 Cummings Center, Suite 247-C&#9;, Beverly, Massachusetts 01915.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This Information Statement
is first being mailed or otherwise provided to the holders of our outstanding common stock, our only class of voting securities
outstanding, on or about &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2018. Each holder of record of shares of our common stock at the close of business on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2018 is entitled to receive a copy of this Information Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Section: Main; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 11pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FREQUENTLY ASKED QUESTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following questions
and answers are intended to respond to frequently asked questions concerning the actions approved by our Board of Directors and
the persons entitled to vote a majority of our outstanding shares of common stock. These questions do not, and are not intended
to, address all the questions that may be important to you. You should carefully read the entire Information Statement, as well
as its appendices and the documents incorporated by reference in this Information Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify"><B>Why isn&#8217;t the Company holding a meeting of stockholders?</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">A:</TD><TD STYLE="text-align: justify">Our Board of Directors has already approved the Certificate of Amendment to our Articles of Incorporation
and has received the written consent of a majority of the voting interests entitled to vote on such actions. Under the NRS, these
actions may be approved by the written consent of a majority of the voting interests entitled to vote. Since we have already received
written consents representing the necessary number of votes, a meeting is not necessary and represents a substantial and avoidable
expense.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify"><B>Can I require you to purchase my stock?</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">A:</TD><TD STYLE="text-align: justify">No. Under the NRS, you are not entitled to appraisal and purchase of your stock as a result of
the Charter Amendment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>Q:</B></TD><TD STYLE="text-align: justify"><B>Who will pay the costs of the Charter Amendment?</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">A:</TD><TD STYLE="text-align: justify">We will pay all of the costs of the Charter Amendment, including distributing this Information
Statement. We may also pay brokerage firms and other custodians for their reasonable expenses for forwarding information materials
to the beneficial owners of our common stock. We are not soliciting any proxies and will not contract for other services in connection
with the stockholder action approving the Charter Amendment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>INCREASE
IN AUTHORIZED CAPITAL STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our Articles of Incorporation
authorize us to issue 300,000,000 shares of common stock and 10,000,000 shares of preferred stock. Our Board of Directors and Majority
Stockholders have approved the Charter Amendment to increase our authorized capitalization to 800,000,000 shares of common stock
and 10,000,000 shares of preferred stock. We are not increasing our authorized preferred stock which will remain unchanged. As
of the date hereof, there are approximately 98,503,199 shares of common stock outstanding and 2,133,332 shares of preferred stock
outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Immediately following the
filing of the Charter Amendment and the associated increase in authorized capitalization to 800,000,000 shares of common stock,
each share of our outstanding preferred stock will be converted into 100 shares of common stock (which is an aggregate of 213,333,200
shares of common stock). In addition, our Board of Directors will have the authority to issue authorized shares of common stock
or preferred stock at such times, for such purposes and for such consideration as the Board may determine to be appropriate without
requiring future stockholder approval of such issuances, except as may be required by applicable law or applicable stock exchange
regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Background; Recent Change of Control</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Securities Purchase Agreement</I></P>


<!-- Field: Page; Sequence: 4; Section: Main; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 11pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On July 3, 2018, BioVie,
Inc., a Nevada corporation (the &#8220;Company&#8221;), entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;)
with Acuitas Group Holdings, LLC (&#8220;Acuitas&#8221;) and certain other purchasers identified in the Purchase Agreement (together
with Acuitas, the &#8220;Purchasers&#8221;) pursuant to which (i)&nbsp;the Purchasers agreed to purchase an aggregate of 2,133,332
shares of the Company&#8217;s newly created Series A Convertible Preferred Stock (the &#8220;Preferred Stock&#8221;) at a price
per share of $1.50 per share of Preferred Stock (the &#8220;Initial Sale&#8221;) and (ii)&nbsp;the Company will issue associated
warrants (the &#8220;Warrants&#8221;) to purchase 213,333,200 shares of the Company&#8217;s Class A Common Stock (the &#8220;Common
Stock&#8221;), each subject to the terms and conditions set forth in the Purchase Agreement, for an aggregate consideration of
$3.2 million. Acuitas also received an additional 833,333 Warrants in connection with the payoff of a note issued by the Company
in favor of Acuitas. The Initial Sale and issuance of the Warrants occurred on July 3, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In addition, Acuitas has
the option to purchase up to an additional 200,000,000 shares of Common Stock at a price per share of $0.015, and associated warrants
on the same terms as the Warrants, within two weeks following the one year anniversary of the closing of the Initial Sale (the
&#8220;Subsequent Sale&#8221;) in the event that the Company has not obtained $3,000,000 of funding through various non-dilutive
grants prior to the one year anniversary of the closing of the Initial Sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Each share of Preferred
Stock will automatically convert into 100 shares of Common Stock upon the filing with the Secretary of State of the State of Nevada
of a Certificate of Amendment to the Company&#8217;s Articles of Incorporation (the &#8220;Amendment&#8221;) that increases the
number of authorized shares of Common Stock to 800,000,000. The Amendment was approved by the written consent of the holders of
more than a majority of the Company&#8217;s issued and outstanding Common Stock on July 3, 2018, and will be filed with the Secretary
of State of the State of Nevada 20 calendar days following the distribution of the Company&#8217;s Definitive Information to be
filed with the Securities and Exchange Commission. See the heading &#8220;<I>Series A Convertible Preferred Stock</I>&#8221; below
for additional information related to the Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The purchase price of the
Preferred Stock in the Initial Sale, the exercise price of the Warrants, and the Common Stock in the Subsequent Sale is subject
to adjustment. First, in the event that the volume weighted average price of the Common Stock during the five trading day period
following July 3, 2018 is less than $0.015 per share, the price per share of Common Stock, the associated conversion ratio of the
Preferred Stock, and the exercise price of the Warrants shall be retroactively adjusted to reflect such lower price. Second, in
the event that Mallinckrodt Pharmaceuticals Ireland Limited prevails in any proceeding which results in the useful life of the
Company&#8217;s current intellectual property rights being reduced by more than 75 percent, then the price per share of Common
Stock, the associated conversion ratio of the Preferred Stock, and the exercise price of the Warrants shall be retroactively adjusted
to 50 percent of the then-effective price per share of Common Stock under the Purchase Agreement (for example, if the then-effective
price per share of Common Stock is $0.015, then following such event, the price per share will be $0.0075). In each case, the Company
may be required to issue additional shares of Common Stock, but in no event will the Company be required to pay cash, to reflect
such lower price per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement
contained customary representations and warranties. In connection with the disclosure schedule associated with the representations
and warranties, the Company also disclosed customary information, including the following: (i)&nbsp;the existence of the Mallinckrodt
Pharmaceuticals Ireland Limited petition before the US Patent Trial and Appeal Board, (ii)&nbsp;the current capitalization of the
Company, (iii)&nbsp;the Company&#8217;s obligation to pay a royalty on the net sales of BIV201 (continuous infusion terlipressin)
in the amount of five percent to be allocated four percent to LAT Pharma LLC members, 0.4 percent to PharmaIn Corporation and 0.6
percent to The Barrett Edge, Inc. pursuant to the Agreement and Plan of Merger, dated April 11, 2016, by and between LAT Pharma
LLC and the Company, (iv)&nbsp;the Company&#8217;s obligation to pay a royalty of five percent on net sales of all terlipressin
products covered by specified patents up to a maximum of $200,000 per year pursuant to the Technology Transfer Agreement, dated
July 25, 2016, by and between the Company and the University of Padova (Italy), and (v)&nbsp;certain recent issuances of Common
Stock by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Section: Main; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 11pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the Purchase
Agreement, Terren Peizer, the Chairman of Acuitas, was appointed as a member of the Company&#8217;s Board of Directors (the &#8220;Board&#8221;)
and as the Chief Executive Officer of the Company, effective July 3, 2018. There are no family relationships between Mr. Peizer
and any other director or officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Jonathan Adams, the Company&#8217;s
prior Chief Executive Officer and a member of the Board, effective upon the appointment of Mr. Peizer, resigned as the Chief Executive
Officer, was appointed as the Company&#8217;s President and Chief Operating Officer, and will continue to serve as a member of
the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The issuance of the Preferred
Stock, the Warrants and the underlying common stock under the Purchase Agreement is exempt from registration under the Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;), pursuant to the exemption for transactions by an issuer not involving
any public offering under Section 4(a)(2) of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Common Stock Warrants</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Warrants have an exercise
price per share of common stock equal to $0.018 (or 120 percent of the price per share of Common Stock equivalent under the Purchase
Agreement), subject to adjustment as provided in the Purchase Agreement and in the event of certain stock dividends and distributions,
stock splits, distributions of indebtedness or assets, or similar events affecting the Common Stock. In the event that the Company
issues additional shares of Common Stock at a price per share less than the then-current exercise price of the Warrants, then the
exercise price shall be reduced to such lower price. The Warrants are exercisable upon issuance and will expire six years after
issuance and include a cashless exercise feature. The Warrants do not contain voting rights or any of the other rights or privileges
of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Series A Convertible Preferred Stock</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On July 2, 2018, in anticipation
of the closing of the Initial Sale under the Purchase Agreement, the Company filed a Certificate of Designation of Preferences,
Rights and Limitations of Series A Convertible Preferred Stock (the &#8220;Certificate of Designation&#8221;) with the Secretary
of State of the State of Nevada. The Certificate of Designation authorized the Company to issue 2,133,332 shares of Preferred Stock.
Each share of Preferred Stock will automatically convert into 100 shares of Common Stock, subject to certain adjustments, upon
the filing of the Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Preferred Stock is
entitled to vote on an as-converted to Common Stock basis. In the event of a dividend or other distribution by the Company, the
Preferred Stock is entitled to payment on a pari passu basis with the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Copies of the Purchase
Agreement, the Warrants and the Certificate of Designation are filed as Exhibits 3.1, 4.1 and 10.1, respectively, to our Current
Report on Form 8-K, filed with the SEC on July 3, 2018. The foregoing description of the terms of the&nbsp;Purchase Agreement,
the Warrants and the Certificate of Designation&nbsp;is only a summary of the material terms of the&nbsp;Purchase Agreement, the
Warrants and the Certificate of Designation and does not purport to be complete. Such description is qualified in its entirety
by reference to such exhibits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Description of Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>General</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We are a Nevada corporation,
and our affairs are governed by our Articles of Incorporation, our By-Laws and the NRS. The following are summaries of material
provisions of our Articles of Incorporation, our Certificate of Designation and the NRS insofar as they relate to the material
terms of our shares of common stock. We have filed copies of our complete Articles of Incorporation, and By-Laws, as amended, as
exhibits in certain of our filings with the Securities and Exchange Commission (the &#8220;SEC&#8221;).&nbsp;&nbsp;The following
summary description relating to our share capital does not purport to be complete and is qualified in its entirety by our Articles
of Incorporation and By-Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 6; Section: Main; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 11pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Shares of Common Stock</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our Board of Directors
believes that the increase in authorized shares of common stock is desirable in order to cause the conversion of the Series A Preferred
Stock, and provide us with a greater degree of flexibility to issue shares of common stock, without the expense and delay of a
special stockholders&#8217; meeting, in connection with future equity financings, future opportunities for expanding the business
through investments or acquisitions, management incentive and employee benefit plans and for other general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">To the extent that additional
authorized shares of common stock are issued in the future, they will decrease our existing stockholders&#8217; percentage equity
ownership and, depending upon the price at which they are issued, could be dilutive to the existing stockholders. The holders of
our shares of common stock have no preemptive rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Voting</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Holders of shares of common
stock are entitled to one vote for each ordinary share on all matters to be voted on by the shareholders. Holders of shares of
common stock do not have cumulative voting rights. Holders of shares of common stock are entitled to share ratably in dividends,
if any, as may be declared from time to time by the Board of Directors in its discretion from funds legally available therefor.
In the event of a liquidation, dissolution or winding up of the Company, the holders of shares of common stock are entitled to
share pro rata all assets remaining after payment in full of all liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Holders of shares of common
stock have no preemptive rights to purchase shares of common stock. There are no conversion or redemption rights or sinking fund
provisions with respect to the shares of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Dividends</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The holders of our shares
of common stock are entitled to such dividends as may be declared by our board of directors. We have not paid any dividends on
our shares of common stock and do not anticipate paying any such cash dividends in the foreseeable future. The payment of dividends
in the future will be within the discretion of our then board of directors. It is the present intention of our board of directors
to retain all earnings, if any, for use in our business operations and, accordingly, our board does not anticipate declaring any
dividends in the foreseeable future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Preferred Stock</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We are currently authorized
to issue 10,000,000 shares of preferred stock, $0.001 par value per share,&nbsp;with designations, rights and preferences determined
from time to time by our Board of Directors. The Charter Amendment will not increase the number of authorized shares of preferred
stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Shares of preferred stock
may be issued from time to time in one or more series, each of which will have such distinctive designation or title as shall be
determined by our Board of Directors prior to the issuance of any shares thereof. Shares of preferred stock will have such voting
powers, full or limited, or no voting powers, and such preferences and relative, participating, optional or other special rights
and such qualifications, limitations or restrictions thereof, as shall be stated in such resolution or resolutions providing for
the issue of such class or series of preferred stock as may be adopted from time to time by the Board of Directors prior to the
issuance of any shares thereof. The number of authorized shares of preferred stock may be increased or decreased (but not below
the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority of the voting power of all
the then outstanding shares of our capital stock entitled to vote generally in the election of the directors, voting together as
a single class, without a separate vote of the holders of the preferred stock, or any series thereof, unless a vote of any such
holders is required pursuant to any preferred stock designation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Section: Main; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 11pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Series A Convertible Preferred Stock</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company is authorized
to issue 2,133,332 shares of Preferred Stock. Each share of Preferred Stock will automatically convert into 100 shares of Common
Stock, subject to certain adjustments, upon the filing of the Charter Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Preferred Stock is
entitled to vote on an as-converted to Common Stock basis. In the event of a dividend or other distribution by the Company, the
Preferred Stock is entitled to payment on a pari passu basis with the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We do not have any current
plans, proposals or arrangements, written or otherwise, to create or issue any additional shares of preferred stock using the &#8220;blank
check&#8221; authority afforded our Board of Directors by the Charter Amendment. However, our Board believes that this authority
is beneficial because it provides us with increased flexibility in pursuit of equity financing. Having authorized &#8220;blank
check&#8221; preferred stock permits us to issue preferred stock for purposes that may be identified in the future, including (i)
to raise additional capital or (ii) to engage in a range of investment and strategic opportunities through equity financings. The
shares of preferred stock permit our Board of Directors to undertake the foregoing actions on an expedited basis, without the delay
and expense ordinarily attendant on obtaining further shareholder approvals. In addition, our Board of Directors believes that
the having authorized &#8220;blank check&#8221; preferred stock improves our ability to attract needed investment capital, as various
series of the preferred stock may be customized to meet the needs of any particular transaction or market conditions. &#8220;Blank
check&#8221; preferred stock is commonly authorized by publicly traded companies and is frequently used as a preferred means of
raising capital. In particular, in recent years, smaller companies have been required to utilize senior classes of securities to
raise capital, with the terms of those securities being highly negotiated and tailored to meet the needs of both investors and
the issuing companies. Such senior securities typically include liquidation and dividend preferences, protections, conversion privileges
and other rights not found in shares of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The issuance of preferred
stock could affect the relative rights of the holders of our shares of common stock. Depending on the exact powers, preferences
and rights, if any, of the preferred stock as determined by our Board of Directors at the time of issuance, the voting power and
economic interest of the holders of our shares of common stock may be diluted. For example, the holders of preferred stock may
be entitled to (i) certain preferences over the holders of our shares of common stock with respect to dividends or the power to
approve the declaration of a dividend, (ii) in the event of liquidation of our company, receive a certain amount per share of their
preferred stock before the holders of our shares of common stock receive any distribution, (iii) rights to convert their preferred
stock into shares of common stock, and (iv) voting rights which would tend to dilute the voting rights of the holders of our shares
of common stock. The aforementioned are only examples of how shares of our preferred stock, if issued, could result in:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">Reduction of the amount of funds otherwise available for payment of dividends on our shares of common stock;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Restrictions on dividends on our shares of common stock;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Dilution of the voting power of our shares of common stock; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Restrictions on the rights of holders of our shares of common stock to share in our assets upon liquidation until satisfaction of any liquidation preference granted to the holders of our preferred stock.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Purpose and Effect of Increasing the Number
of Our Authorized Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Section: Main; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 11pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As discussed in detail
above under &#8220;Increase In Authorized Capital Stock &#8212; General&#8221;, we may be required to issue part of the additional
authorized common shares resulting from the increase in the number of our authorized shares of common stock upon conversion of
the Series A Preferred Stock or the exercise of the Warrants. Except as we may be required to do so upon conversion of the Series
A Preferred Stock or the exercise of the Warrants, we have no other current plans, proposals or arrangements, written or otherwise,
to issue any of the additional authorized common shares resulting from the increase in the number of our authorized shares of common
stock. In addition, please see above under &#8220;Description of Securities &#8212; Shares of Common Stock&#8221;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Interest of Certain Persons In Favor of
or Opposition to Matters Acted Upon</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">None of the directors or
executive officers of the Company has any substantial interest resulting from the increase in authorized capital stock, except
for the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Terren Peizer, is the Chairman of Acuitas, which purchased $3,000,000 of Preferred Stock, and acquired Warrants to purchase 200,000,000 shares of Common Stock in connection with the Transaction. However, the Closing of the Transaction was conditioned on the prior approval of the stockholders and Mr. Peizer did not have the right to vote his shares in connection with the approval of the Charter Amendment;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Cuong Do, a director, purchased $130,000.00 of Preferred Stock, and acquired Warrants to purchase 8,666,600 shares of Common Stock in connection with the Transaction;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Jim Lang, a director, purchased $30,000.00 of Preferred Stock, and acquired Warrants to purchase 2,000,000 shares of Common Stock in connection with the Transaction;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Michael Sherman, a director, purchased $25,000.00 of Preferred Stock, and acquired Warrants to purchase 1,666,600 shares of Common Stock in connection with the Transaction; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Jonathan Adams, a director and our current President and Chief
    Operating  Officer who was the President and Chief Executive Officer prior to the Transaction, purchased $15,000.00 of
    Preferred Stock, and acquired Warrants to purchase 1,000,000 shares of Common Stock in connection with the
    Transaction.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Procedure to Effect the Share Increase</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In order to effect the
increase in the number of our authorized shares of common stock, we will file a Certificate of Amendment with the Secretary of
State of the State of Nevada to amend our existing Articles of Incorporation. The share increase will become effective at the time
specified in the Amendment, which is referred to below as the &#8220;effective time.&#8221; A copy of the form of Certificate of
Amendment to our Articles of Incorporation to be filed in connection with the Charter Amendment is attached to this Information
Statement as <U>Appendix A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Charter Amendment has
received the unanimous approval of our Board of Directors and has also been approved by stockholders holding a majority of our
outstanding common stock. The text of the form of Charter Amendment attached hereto as <U>Appendix A</U> is subject to modification
to include such changes as may be required by the office of the Secretary of State of the State of Nevada and as the Board of Directors
deems necessarily and advisable to effect the increase in the number of our authorized shares of common stock, including the insertion
of the effective time determined by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Section: Main; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 11pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As soon as practicable
after the effective time, stockholders will be notified that the increase in the number of our authorized shares of common stock
has been effected through the filing of a Current Report on Form 8-K with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Possible Anti-Takeover Effects of the Proposed
Increase in Authorized Capital Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The increase in authorized
capital with respect to the authorized number of shares of common stock and the subsequent issuance of such shares could have the
effect of delaying or preventing a change in control of our company without further action by our stockholders. Authorized and
unissued shares of common stock could be issued (within the limits imposed by applicable law) in one or more transactions. Any
such issuance of additional shares of common stock could have the effect of diluting the earnings per share and book value per
share of outstanding shares of common stock, and such additional shares could be used to dilute the stock ownership or voting rights
of a person seeking to obtain control of us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our Board of Directors
acknowledges that the issuance of preferred stock may have the effect of discouraging or thwarting persons seeking to take control
of us through a corporation transaction, tender offer or a proxy fight or otherwise seeking to bring about the removal of our incumbent
management. Because the authorization of &#8220;blank check&#8221; preferred stock could be used by our Board of Directors for
the adoption of a shareholder rights plan or &#8220;poison pill,&#8221; the preferred stock may be viewed as having the effect
of discouraging an attempt by another person or entity to acquire control of us through the acquisition of a substantial numbers
of shares of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">While the Charter Amendment
may have anti-takeover ramifications, our Board of Directors believes that the reasons for such Charter Amendment set forth above
outweigh any disadvantages. To the extent that such amendment may have anti-takeover effects, such amendment may encourage persons
seeking to acquire our company to negotiate directly with the Board of Directors, enabling the Board of Directors to consider the
proposed transaction in a manner that best serves our stockholders&#8217; interests. The Charter Amendment has not been made in
response to, and is not being presented to deter, any effort to obtain control of us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>No Pre-Emptive Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Holders of our common and
preferred stock do not have any pre-emptive or similar rights to acquire or subscribe for or purchase any additional shares of
any class of capital stock that may be issued in the future and, therefore, future issuances of our common stock may, depending
on the circumstances, have a dilutive effect on the earnings per share, voting power and other interests of our existing stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>No Dissenters' Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In connection with the
approval of the number of our authorized shares of common stock, you and our other stockholders will not have a right to dissent
and obtain payment for their shares under the NRS or our Articles of Incorporation or By-laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Financial Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our audited financial statements
and accompanying notes filed with our Annual Report (our &#8220;Annual Report&#8221;) on Form 10-K for the year ended June 30,
2017, as amended, are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our unaudited condensed
interim financial statements and accompanying notes filed with our Quarterly Report on Form 10-Q (our &#8220;Quarterly Report&#8221;)
for the period ended March 31, 2018, are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Section: Main; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 11pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Item 7 of Part II of our
Annual Report &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; is incorporated
herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Item 2 of Part II of our
Quarterly Report &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; is incorporated
herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>SECURITY OWNERSHIP OF
CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets
forth information known to us with respect to the beneficial ownership of our common stock as of July 3, 2018, unless otherwise
noted, by:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">each stockholder known to us to own beneficially more than 5% of our common stock;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">each of our directors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">each of our executive officers; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">all of our current directors and executive officers as a group.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Beneficial ownership is
determined in accordance with the rules of the SEC and generally includes voting or dispositive power with respect to securities.
Common shares relating to options, warrants or convertible debentures currently exercisable, or exercisable within 60 days of July
3, 2018, are deemed outstanding for computing the percentage of the person holding such securities but are not deemed outstanding
for computing the percentage of any other person. Except as indicated by footnote, and subject to the community property laws where
applicable, the persons or entities named in the tables have sole voting and dispositive power with respect to all shares shown
as beneficially owned by them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Section: Main; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 11pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt"><B>Name and Address of Beneficial Owner</B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number of Common Shares of Beneficial Ownership <SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Percentage of Beneficial Ownership <SUP>(2)</SUP></B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom; width: 52%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Terren Peizer<B><SUP>(3)</SUP></B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">400,833,333</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">80.3%</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Jonathan Adams<B><SUP>(4)</SUP></B></FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">8,136,248</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">8.1%</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Julie Anderson</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">368,500</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">&nbsp;Cuong Do<B><SUP>(5)</SUP></B></FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">20,537,888</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">17.7%</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">James Lang<B><SUP>(6)</SUP></B></FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">5,328,788</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">5.2%</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Hari Kumar</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">427,272</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Michael Sherman<B><SUP>(7)</SUP></B></FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">3,935,472</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">3.9%</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Mina Sooch</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">613,636</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt"><B>All Directors and executive officers as a group (eight persons):</B></FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>440,181,137</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>83.6%</B></FONT></TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt"><B>Other 5% or Greater Beneficial Owners:</B></FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Acuitas Group Holdings, LLC<B><SUP>(8)</SUP></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">11601 Wilshire Boulevard</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Suite 1100</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Los Angeles, CA 90025</P></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">400,833,333</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">80.3%</FONT></TD></TR>
<TR STYLE="background-color: #CCECFF">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Elliot Ehrlich<B><SUP>(9)</SUP></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">9511 Collins Ave #807 Surfside, FL 33154</P></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">7,662,500</P></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">7.8%</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Leo and Helene Ehrlich</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">7846 Tennyson Ct. Boca Raton, FL 33433</P></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">8,500,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">8.6%</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Rebecca Guttman</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">655 Ibsen St., Woodmere, NY 11598</P></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">8,500,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">8.6%</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">RGN Brothers Trust</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">2715 Avenue L, Brooklyn, NY 11210</P></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">8,500,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">8.6%</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">*&nbsp;Less
than 1%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Beneficial ownership is determined in accordance with the rules of the SEC, which include holding voting and investment power with respect to the securities. Shares of common stock subject to options, warrants or Series A Preferred Stock currently exercisable or convertible, or exercisable within 60 days of July 3, 2018, are deemed outstanding for computing the percentage of the total number of shares beneficially owned by the designated person, but are not deemed outstanding for computing the percentage for any other person.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 12; Section: Main; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 11pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Percent of class based on 98,503,199 shares of common stock outstanding as of July 3, 2018.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; background-color: white">Mr.&nbsp;Peizer is affiliated with Acuitas Group Holdings, LLC, and may be deemed to have voting and investment power over the shares held of record by Acuitas Group Holdings, LLC, and Mr. Peizer, may be deemed to have voting and investment power over the shares held of record by Acuitas Group Holdings, LLC. Includes (i)&nbsp;200,000,000 shares of common stock, issuable upon the exercise of warrants to purchase common stock that are exercisable within 60 days of July 3, 2018, and (ii)&nbsp;200,833,333 shares of common stock, issuable upon the exercise of warrants to purchase common stock that are exercisable within 60 days of July 3, 2018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; background-color: white">Includes (i)&nbsp;1,000,000 shares of common stock, issuable upon the exercise of warrants to purchase common stock that are exercisable within 60 days of July 3, 2018, and (ii)&nbsp;1,022,727 shares of common stock, issuable upon the exercise of warrants to purchase common stock that are exercisable within 60 days of July 3, 2018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; background-color: white">Includes (i)&nbsp;8,666,600 shares of common stock, issuable upon the exercise of warrants to purchase common stock that are exercisable within 60 days of July 3, 2018, and (ii)&nbsp;8,833,267 shares of common stock, issuable upon the exercise of warrants to purchase common stock that are exercisable within 60 days of July 3, 2018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; background-color: white">Includes (i)&nbsp;2,000,000 shares of common stock, issuable upon the exercise of warrants to purchase common stock that are exercisable within 60 days of July 3, 2018, and (ii)&nbsp;2,348,485 shares of common stock, issuable upon the exercise of warrants to purchase common stock that are exercisable within 60 days of July 3, 2018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; background-color: white">Includes (i)&nbsp;1,666,600 shares of common stock, issuable upon the exercise of warrants to purchase common stock that are exercisable within 60 days of July 3, 2018, and (ii)&nbsp;1,700,691 shares of common stock, issuable upon the exercise of warrants to purchase common stock that are exercisable within 60 days of July 3, 2018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; background-color: white">Includes (i)&nbsp;200,000,000 shares of common stock, issuable upon the exercise of warrants to purchase common stock that are exercisable within 60 days of July 3, 2018, and (ii)&nbsp;200,833,333 shares of common stock, issuable upon the exercise of warrants to purchase common stock that are exercisable within 60 days of July 3, 2018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(9)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; background-color: white">Includes 62,500 shares of common stock, issuable upon the exercise of warrants to purchase common stock that are exercisable within 60 days of July 3, 2018</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 13; Section: Main; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 11pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>STOCKHOLDERS SHARING AN ADDRESS</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Unless we have received
contrary instructions from a stockholder, we are delivering only one Information Statement to multiple stockholders sharing an
address. We will, upon request, promptly deliver a separate copy of this Information Statement to a stockholder who shares an address
with another stockholder. A stockholder who wishes to receive a separate copy of the Information Statement may make such a request
in writing to the Company at BioVie Inc., 100 Cummings Center, Suite 247-C, Beverly, MA 01915, or by telephone at (312) 283-5793.
If you are currently receiving multiple mailings at one address and would like to request a single mailing at one address, you
may do so by contacting the Company as indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ADDITIONAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We are subject to the disclosure
requirements of the Exchange Act and in accordance therewith, file reports, information statements and other information, including
annual and quarterly reports on Form 10-K and 10-Q, respectively, with the SEC. Reports and other information filed by us can be
inspected and copied at the public reference facilities maintained by the SEC at Room 1024, 450 Fifth Street, N.W., Washington,
DC 20549. Copies of such material can also be obtained upon written request addressed to the SEC, Public Reference Section, 450
Fifth Street, N.W., Washington, D.C. 20549, at prescribed rates. In addition, the SEC maintains a web site on the Internet (http://www.sec.gov)
that contains reports, information statements and other information regarding issuers that file electronically with the SEC through
the Electronic Data Gathering, Analysis and Retrieval System.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">You may request a copy
of these filings, at no cost, by writing BioVie Inc. at 100 Cummings Center, Suite 247-C, Beverly, MA 01915, attention Corporate
Secretary, or telephoning the Company at (312) 283-5793.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This Information Statement
is provided to our stockholders only for information purposes in connection with the Authorized Share Increase, pursuant to and
in accordance with Rule 14c-2 of the Exchange Act. Please carefully read this Information Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Dated: July 3, 2018</FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">BY ORDER OF THE BOARD OF DIRECTORS</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 31%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 15%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ Jonathan Adams</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name: Jonathan Adams</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title: Chief Operating Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 14; Section: Main; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 11pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>APPENDIX A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Form of Certificate of Amendment</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>to the Articles of Incorporation of BioVie
Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>
<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>
<IMG SRC="image_001.jpg" ALT="" STYLE="border: Black 2pt solid">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>
<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ,, E@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHKC_$/_)2_!G^Y?\ _HM* .PHKY:OO^2A:'_UYZE_Z57]0^%/^27:
MA_UXZI_Z,T^@#ZKHKP'XH_\ )'[C_L:KS_THN:Y>R_Y'_6_^O#2__2FPH ^I
MJ*^:U_Y+9X1_Z[W?_IPO:7Q9_P E(T;_ +'.?_T&QH ^DZ*^>M#_ -=X4_W]
M,_\ 2N^KGO'_ /R/OQ+_ .P=!_Z46= 'U-17S3H?_'EI?_<)_P#1%]5_X7_\
MD4OO^QFM/_1UG0!]#T5\LV'_ "//A[_L!7__ *#>UU>H?\D(\5_]PW_TDL:
M/>Z*^1(O^0OH_P#V*5Y_Z275>P>&_P#DJ2?]?%__ .DNGT >MT5\J>%/^/#Q
M1_U^W'_IOU"NO^!/_'WI/_8,O_\ THMZ /?**^2/^8[_ -R?_P"V5>E? S[U
MA_V !_Z7W= 'MM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7'^(?^2E^#/\ <O\
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M -*+>N2\+0RK8^)@T;@M>W&W*GG_ (E^H=*Z_P"!<<D=WI6^-EQIM^#N&/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&WR!0[9]6"*">^T5!_PBN@"RDLQH]D+:2%;=X1"-IC5BRKCT#,QQZF@#G?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KS_P 4^./$.F>-HO#/A_PY%J]P]@+X[[M8"J[V
M0_>X[#OGFO0*\XE_Y.+@_P"Q9/\ Z4-0 W_A*OBC_P!$XM__  <0_P"-'_"5
M?%'_ *)Q;_\ @XA_QKTFB@#S;_A*OBC_ -$XM_\ P<0_XT?\)5\4?^B<6_\
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M1U4LUUDA1@XP0>=V>-N,Y(&*QO\ A:OA*X\-ZKK6G:FEY%IL6^6,(\;DGA%
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M&>/S$V[EWC*[C\N1VSVH \*DTRQM?!'PFN(+.&*=M9LRTBH QWG<V3UY(!_
M5K>"9=/T7XV>*]*N=+>.]OKA9+%UM1MCC".SG=_"IRO3J<5[)@48% "T444
M%%%% 'GU_P#\E[TG_L!3?^C:]!KSZ_\ ^2]Z3_V IO\ T;7H- !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-CJ-TD&D3VMFEK%$)[JR6TF+*6_=L$.R7 .=ZJ ,D MGBEK7AH7$7B*\BT1
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7G$O_)Q<'_8LG_TH:O1Z\UNIHH/VB('FD2-?^$:QEV
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_0O?^3MQ_P#'*[\9QSUI: //_P#A27P\_P"A>_\ )VX_^.4?\*2^'G_0O?\
MD[<?_'*] HH \_\ ^%)?#S_H7O\ R=N/_CE'_"DOAY_T+W_D[<?_ !RO0**
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M*5?!&/O;\GFO8] ANK?PYI<%\<WD=I$DY]9 @#?KF@#1HHHH **** "BBB@
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MV_29]2M(8D<_9MFS"2MO_><2!2P"89<8YX /1H[2VBGFGCMXDFG*F614 :3
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MQO\ GD_YC_&I** (_,;_ )Y/^8_QH\QO^>3_ )C_ !J2B@"/S&_YY/\ F/\
M&CS&_P">3_F/\:DHH C\QO\ GD_YC_&CS&_YY/\ F/\ &I** (_,;_GD_P"8
M_P :/,;_ )Y/^8_QJ2B@"/S&_P">3_F/\:/,;_GD_P"8_P :DHH C\QO^>3_
M )C_ !H\QO\ GD_YC_&I** (_,;_ )Y/^8_QH\QO^>3_ )C_ !J2B@"/S&_Y
MY/\ F/\ &CS&_P">3_F/\:DHH C\QO\ GD_YC_&CS&_YY/\ F/\ &I** (_,
M;_GD_P"8_P :/,;_ )Y/^8_QJ2B@"/S&_P">3_F/\:/,;_GD_P"8_P :DHH
MC\QO^>3_ )C_ !H\QO\ GD_YC_&I** (_,;_ )Y/^8_QH\QO^>3_ )C_ !J2
MB@"/S&_YY/\ F/\ &CS&_P">3_F/\:DHH C\QO\ GD_YC_&CS&_YY/\ F/\
M&I** (_,;_GD_P"8_P :/,;_ )Y/^8_QJ2B@"/S&_P">3_F/\:/,;_GD_P"8
M_P :DHH C\QO^>3_ )C_ !H\QO\ GD_YC_&I** (_,;_ )Y/^8_QI5D+,5*,
MI SSC^AI],'^O/\ NC^9H ?1110 4444 %%%% !1110 4444 %9/B*QGU30M
M2TZV,:S7=E+ C2$A5+KMR< GC.>E:U1G_7C_ '3_ #% '(3>$[R1+YH([&S:
M;29-/$4#,$F=L8DD(4#Y,,%PI/SOSSBK6E:!J&BWEU>6K6SO>P6XN(9'8*DT
M2>7O5@N6!4(-I"_<SGYCCJ:* .-E\!H/".FZ-;7TD=Q92F07@7#$R;Q<$#G:
M6667 Z*2O]VM.]TF[;Q%I-_916JV]A;7$/E,Y0DN$V@ *0 -@'X]..=^B@#F
M?"N@76@6&FV;6^GQ_9[&*VN9X"2]PT:A5_A&!DN><GD>]03^']4:?67C%F1>
MZM:7\6Z9AA(?(!5ODX)\CC&?O>W/6T4 <3/X 7?J8L[W[-%*]K/8)Y>Y;.:&
M5YN!GYHR[YV]@6 P-N.@A_MQE,EPMC&X**L,;NZ[=PWN7*@YVYVJ!@'J3GY=
M:B@!!TI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *8/]>?]T?S-/I@_P!>?]T?S- #Z***
M "BBB@ HHHH **** "BBB@ J,_Z\?[I_G4E-9$<C>JL1TR,T .HJ/R8?^>2?
M]\BCR(?^>2?]\B@"2BH_(B_YY)_WR*/(B_YY)_WR* )**C\B+_GDG_?(H\F'
M_GDG_?(H DHJ/R(?^>2?]\BCR8?^>2?]\B@"2BH_(B_YY)_WR*/(A_YY)_WR
M* )**C\B+_GDG_?(H\B+_GDG_?(H DHJ/R(O^>2?]\BCR(O^>2?]\B@"2BH_
M(B_YY)_WR*/(B_YY)_WR* )**C\B+_GDG_?(H\B+_GDG_?(H DHJ/R(O^>2?
M]\BCR(O^>2?]\B@"2BH_(B_YY)_WR*/(B_YY)_WR* )**C\B+_GDG_?(H\B+
M_GDG_?(H DHJ/R(O^>2?]\BCR8?^><?_ 'R* )**C\F'_GG'_P!\BCR(?^>2
M?]\B@"2BH_(B_P">2?\ ?(H\B+_GDG_?(H DHJ/R(O\ GDG_ 'R*/(B_YY)_
MWR* )**C\B+_ )Y)_P!\BCR(O^>2?]\B@"2BH_(B_P">2?\ ?(H\B+_GDG_?
M(H DHJ/R(O\ GDG_ 'R*/(B_YY)_WR* )**C\B+_ )Y)_P!\BCR(O^>2?]\B
M@"2BH_(B_P">2?\ ?(H\B+_GDG_?(H DHJ/R(O\ GDG_ 'R*/(B_YY)_WR*
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M,I.$)V\X5K^,?%-YI][?6DNEV@T_1?[2DC>'[0)V$EPH"M',5576$'AGV[L
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MY65U# '#;4(.,$EV!.^LN_\ "&H37VIW]K-:QW,FIPW]L"[JL@2!83'*5 8
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MZFO]+,%SYB%5>\\LQ"?O@&,[2,<[5/7FB;P=?R7[7(-DNY]+9L,Q/^BN7?\
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M110 4444 %%%% !3!_KS_NC^9I],'^O/^Z/YF@!]%%% !1110 4444 %%%%
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MMO'//'&]Q)Y4*LV#(^"=H]3@$_A5C- !115>VOK6\>X6VN(Y6MI3#,$8'9(
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MYW5[1H2-Z;7 ;$FY.#R,/G VBNPJ"&RMK>XN+B&%$FN&#3.!RY"A1G\ !^%
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M2QG*.H93Z@]*?1THH *8/]>?]T?S-/I@_P!>?]T?S- #Z*** "BBB@ HHHH
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MXQVQGGI4'@S2]0L]4>6XA18%B>)8WLY(7M09"XB5FD=9%RS<KQP/FQ@5W=%
M'-P>%Y+>X@9;M7BM-0N=1ME:/#>9.)<JYSRH,\AX )^7^Z2VCX=TR71/#FFZ
M5+,DQLK:.V$B*5#A%"@XR<9 Z9K3HH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *8/\
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MWM9)8YY)08Q&T9(?.X#@8//3OFDMM9L;N62*.5TDC6-F2:)XF D)"'#@=2I
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M454<2"-@CJV2K(Q&'!P>5)%7: "BBLZ'7M-N-(.JI<$68=HR[QLIW*YC*[2
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M&,DJ(/%46EP7$<>HO)'9VHU&V>XS)+,LJ&80DL "8_,Y4JK;E Y!V^B8%&*
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MZ5]IE"PQ+Y,^]01E%!'!/R-EE_B)R,=M<"SN[9[>5XVBGW0D!\;C@AE!!SG
M;ISP:P+>'1_#3+>"[O+^:6XCTX337)N'AW, (\D_* 2"W\1XSG P <U=>*]1
M@\=S:7<:EYL,ER8$LX##\J%>-T+JLXQ]XRJSIC)P!PN;8:UJGAKPCH:OKDIM
M+KP_#<)_HT&;0K);1@1EBJ[2L^"TI(4J&SC*GUN&6&XB6:%XY$8<.A# CV(I
MGVNS)9/M$&4)5AO'RXQD'TZK^8H \XT/Q+K.NVEG;1ZS+%YFO/8_;$%O-*\
MLFN "54Q%MV!N5<8 ^]R35T3QEXEO[^X0WEL;G[/=M-8OB9K-XPVS]U%'YHP
MP52')WY^7G KU!+RQD,(CN;=C-N\K:ZG?M^]M]<<YQTI3=VB2RH9X!)&F^12
MX!5?4^@]Z .*^'WB>XUJZO[2XU!]0,,<<GFB:VN(UW%A@2P*G7 (1XU88)R<
MX&&FLZZ\?B![3638PZ79WMZD4-I!B21;V\4;LH?E*Q -C!)YW Y+>D:=K6F:
MI8V=Y9W<+PWR"2W^8!I!C/3KD#J.H[U:6YM6F,"S0F4*28PPW8!P3CKU/ZT
M<KXX=I_!=G=OJ,FGHM]I\TL\9C 1?M$623(K *N=^?\ 8&<KD'E=*U+6M#T.
MQO-,OVU**\NM5CBT]H8RCNGVF5&1D 8LS18/)!#G &!7JJW-M)*8%FB:3!/E
MA@3@'!X]CQ48U"P*J1=VQ!944B1>6894#GJ0<CUH XKX>^(]3UN\NH[G4[?4
M;9;:.7S4ECD:.5B<KF)%500,[&RZXY)!XJ7WBO4H+O5VBUM1K%K<7$=KX=^R
M"4SQI&S1G:N)<O@/Y@;8 =N,\UZ)]IMEF$'G1"5F($>X;B<9/'K@@_2D^TVH
MED3SH?,B7=(NX91>N3Z"@#S4>)K^6%K;2O%O]JPR2:<IU.*& F%YK@1R1@*N
MSE?F"L"R]R<BI)/$>I6GB2]L!XG^T7=IJEI9V^E2Q0"2ZA>.#S7;:H;(\R1\
MK@+M.05X'97?B?2;:\>Q2>.XO1!+<"WA=-S",C<,DA0V6'!(Z$]C5JQM+&SO
M]0\B13<W<PNKB,N"P.Q(P<=0-L:T >;P>,M8;0+V[BUU+V^.@WE]=VRPQ+_9
M-U&JE(]H&X8+,NV7<3Y>>S"G>)_%>J^&]<%@OB*>XGA:W)BGBM(4D#R?/E3^
M]E&TX!C50H'S,Q#$>H0W-K=,ZP3PS%0I<(X; 894G'J.1ZBG/-;K.D#R1B:0
M'9&S#<P'7 [T >1SZK?Z/XO\1BSOS?W\5Q>7$5C/%$[ K81/&0%0. Q&W@_,
M$[G<3J)XCU*2TO8-)\4)JT0ETQ8]5$,+B*2>Z$4L>$ 0_)AMI^9=_)Y4CM-&
M\0V6NO?/:1OY%G.T!N7*;)&4D-MPQ; ((RP&>HR.:ATSQ?HFKW!AM+E&01K*
M)6PJ,6D= H).=VZ-CC'0@]Z &^';K4-VMV5W=OJ$FG7OD0S2(B/(I@BE ;8
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MAW:!E!W%@)(YHV'E_-R8R'ZC!XQT>K>,--T:]DM;B.[D,$2SW4D$#2):Q,2
M\A'0?*QXR0%)( YJSIOB"#5;^\M;:UN]MI(T,L[Q;8C(K8*J2<L>^0,>^>*
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M<588."-IW!<&M#3_ !!9:EI5S?Q"5%M6=;B&5-LD3J Q5AZX((P2""""00:
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M1$Y&&;G (YS48_X2C1OAYK\VN:E!+J<5K<SPW%J#B/\ =EP!D#[K$@>RJ>^
M 2VWP_M].TVU@TW4KJVNK2[:Y@NB%D(!C\E8V5LAE$05.Q^0'(-%_P##RTO]
M/MK.74;K8D5U%<.50M<?:)%ED8_+A6\Q%88&T<C!!Q567QOJ6G6\L>I:3:07
M*6]M.C/JBB+9*S)F1R@VL"A^5%?)("YJ;3_B%;S:?:7]_:BTLY7NX9;@2ETC
MD@!?C**Q5HTD8$JI&S&.0: -;POX5M_#,-P(GA>6X*^8T-I%;+A<X 2-0.Y.
M3DY/I@"CIO@]]&DMIFU2^U"#3WFN+.R*1KMED#@_-@9XD=5#' W')Z8SK?XA
MW4NJPV,V@RQ.'MX;M%>622&65(V(&V(H502KN+.I^5B%X&[H-=\3Q>'KL"\@
M/V5[2:>.56Y>2, ^2%QRS*25YR=K<<4 0>!M ?P_X>\F:$PW%Q,\[PF7S/)4
MX6.+=T.R)8TXX^3CBJD?@0I:V]BVNWSZ=9M#]CM"$"Q+%+'(JL0,R8\L*"W0
M$]3S2#QAJ*S9DT6$6L-W;Z?=R+>Y>.XE$8PJ>7AT5YD4MN!ZD*<#.#:?$75[
M6QCAO=-@NM1>6[?]U-,4$4=PT:C,=NQW9!494 A Q8%MH -BU^&UI:ZV^J#4
MIS,6G_>+#&LQ$H8'=,%\QBNX;23@!1P>M1V_PQM+>UOT%\!+=^4'\NPMTA=8
M]Q DA";)"2[$DCLNW;@5#K/C#5;W3Y9M)TY[6T@N;&*>XN)_+N$:5H)"@AVD
M<),JME@<EL XYV/%7B-O#UT+A;>6X\K2KR[$(GV(YC> 8(VGD^9PW;YN#G@
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MN8@ZVT(E'G1M&0\H4/(JASM5CV7))4&NW\I/0_F:/*3T/YF@#FV\'Q'5C/\
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M59U4*&"$[5.  2H&<#.<5DIX&\/1_9Q'8ND<,<,8B2YE5)%B $?F(&VR[0
M7#'  [5T=% %>&!;=PBLY!WN2\C.<LVX\L2<9)P.@& ,  58IC1EG#!RI (Z
M?Y]*-C_\]3^0H ?13-C_ //4_D*-C_\ /4_D* 'T4S8__/4_D*-C_P#/4_D*
M 'T4S8__ #U/Y"C8_P#SU/Y"@!]%,V/_ ,]3^0HV/_SU/Y"@!]%,V/\ \]3^
M0HV/_P ]3^0H ?13-C_\]3^0HV/_ ,]3^0H ?13-C_\ /4_D*-C_ //4_D*
M'T4S8_\ SU/Y"C8__/4_D* 'T4S8_P#SU/Y"C8__ #U/Y"@!],'^O/\ NC^9
MHV/_ ,]3^0H5"KEBY8D8Z4 /HHHH **** "BBB@ HHHH **** "BBN>\7:Z^
MBZ;$D D6YO)/(CG%N\R6_&3(ZJ#D*!PO\1P. 20 =#1FN9^'VH'4_ 6C73W,
MUS*UNJR33;M[N."26Y)SWK ODO;WQIKD0T[7+^"!H%C^Q:T]HD68@2-@F0$Y
MYS@]: /1,CUI:\CUM?$MSXCU=8M8$5N=9M=.1%FN4V1-'%(  DH SGYF&&.6
M&X XK1L/B5J+:7/J5UHS&T;3)=1MU$<L6U5"E4:21=K[@XRZ\+@\,"#0!Z7D
M"BN"OM2\61^(-"TZ:ZT6.1[Y?.%OYC&2-K>X;#(2"H!A?!R0Q /&UE,.B>-;
MR33=)LC;1"]OX-/DL5:5Y-\4J9E+%R69HQ',2<G(V9.6H ]#HS7">%O'.H:_
MJEJLNF/%87Z.]N_V>5#$%Y&]V&R3<,YV?=.!\P.X1>+==UF1-8BL&M[>STZ[
MM;6603.MRSR&%]R%> N)%7!R6^8<8Y /0**X&T\::I?Z_P#V;#'9&*ZCN?LL
MRV]QY<;Q_=S*RJDP/.?+/&,9/6L30OB%KRZ3IJSV9OC;V=HUY*EM*S3F6-'R
M'&40A7!)8_,P(^08- 'K-%<SXKU[4-(-I!IL=N\\XD8EX)[AP$V](85+$$L
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M2^'-0O-6T2QU.Y$*K>6D%PL<:D%2Z!F!))SR>/;UH U\BBN#MM=U:>Z$6GF
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M57L;I;[3[:[12JSQ+*%/4!@#C]:L4 %%<9J>E6NM?$![:^$[P1:4DB)'<R1
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M?_GL_P"0_P */+?_ )[/^0_PJ2B@"/RW_P">S_D/\*/+?_GL_P"0_P *DHH
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MIT4 9MQX=T2\,INM'T^<S1K#(9;9&WHI!56R.5! (!X! JQ;Z;8V@@%M96\
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MRW)#>5<1+(N1T.",9JW10!4M],L+1H6MK*WA,$7D1>5$J^7'D'8N!PN0..G
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXM:*_P!6N=59E\0V<"&5T,C%PZJHY*]_<$ X;CW56W(K#.",\C'Z4 +1110
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MFK5%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%W<1D6;LTYC6$QQONC3!9FE&%4$JN!\P+!MSJ/B"7Q!&UO)?*X,D#I_9[^3
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MN'>T::T9))56VBQMB(3/S!AQM#'.,9H ZZBO+I;_ ,2WKQ22OJD,=O.5$]O
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M%+6XMM-NS=374LTNHW;EKG[VWSW5,<#Y=BKCM@C'&* -VBBB@ HHHH ****
M"BBB@ HHHH *S]5U-M.6U2&W-Q<W<WD01;]@9MK.<MV 5'/?I@#)K0K*UV?2
M([>VM]9-OY-W<)!"L^,-*<E0,_Q?+QCG/2@##U#QPL6B37=I8OY_DLT:3,
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MZ#&T\UUM% 'G=KX)UJ]CDBOKY;"%+6WL46 DF2*)9@=Q5EW?ZX8)^4E<F(<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
>444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
